Korea S.E.
06:00:00 2024-04-25 pm EDT
5-day change
1st Jan Change
591
KRW
-2.31%
-3.11%
-7.66%
Kumho HT, Inc announced that it has received KRW 4.99999955 billion in funding from Eco Volt Co.,Ltd.
On January 22, 2024, Kumho HT, Inc closed the transaction.
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 19.0999977 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD.
Apr. 17
CI
Hwail Pharmaceutical Co.,Ltd. announced extension to the offering period
Jan. 24
CI
Kumho HT, Inc announced that it has received KRW 4.99999955 billion in funding from Eco Volt Co.,Ltd.
Jan. 21
CI
An unknown buyer cancelled the acquisition of 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc.
Dec. 13
CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 25.999996662 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD.
23-10-11
CI
Kumho HT, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-11
CI
An unknown buyer agreed to acquire approximately 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc for KRW 28 billion.
23-03-29
CI
Kumho HT, Inc's Equity Buyback announced on September 28, 2022 has expired with 6,260,000 shares, representing 3.29% for KRW 6,814.16 million.
23-03-26
CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.
23-03-26
CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.
23-03-26
CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.
23-03-26
CI
Kumho HT, Inc announced that it has received KRW 8.7 billion in funding from BH Co., Ltd.
22-11-02
CI
Kumho HT, Inc announced that it expects to receive KRW 10 billion in funding from BH Co., Ltd.
22-10-24
CI
Kumho HT, Inc announces an Equity Buyback for KRW 7,000 million worth of its shares.
22-09-27
CI
Kumho HT, Inc authorizes a Buyback Plan.
22-09-27
CI
CrystalGenomics, Inc. announced that it has received KRW 5.7075 billion in funding from Kumho HT, Inc
22-08-07
CI
CrystalGenomics, Inc. announced that it expects to receive KRW 5.7075 billion in funding from Kumho HT, Inc
22-07-28
CI
Kumho HT, Inc announced a financing transaction
22-05-06
CI
An unknown buyer agreed to acquire approximately 16.5% stake in DiNonA Inc. from Kumho HT, Inc for KRW 19.9 billion.
21-11-02
CI
Kumho HT, Inc. completed the acquisition of remaining 81% stake in DiNonA Inc..
21-10-26
CI
Kumho HT, Inc(KOSE:A214330) added to S&P Global BMI Index
21-09-20
CI
CrystalGenomics, Inc. announced that it has received KRW 15.24 billion in funding from Kumho HT, Inc.
20-09-17
CI
Kumho HT, Inc. agreed to acquire remaining 81% stake in DiNonA Inc. for approximately KRW 170 billion.
20-08-26
CI
An unknown buyer agreed to acquire a 8.5% stake in Kumho HT, Inc. for KRW 17.2 billion.
20-08-17
CI
Kumho HT, Inc. acquired 3.11% stake in CrystalGenomics, Inc. from Jung-myeong Cho for KRW 28 billion.
20-07-30
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
KUMHO HT, INC is a Korea-based company mainly engaged in the manufacture of automotive lighting components. The Company operates its business through two segments: light emitting diode (LED) modules segment, which manufactures fog lamps, side marker lamps, turn signals, side repeaters, daytime running lights (DRLs), rear combination lamps (RCLs), stop lamps, back-up lamps, center high mounted stop lamps (CHMSLs) and others, and incandescent lamps segment, which manufactures wedge bulbs, festoon bulbs and others. The Company distributes its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-7.66% 87.48M +6.28% 8.03B -1.98% 5.07B +10.31% 2.92B +2.97% 2.61B -16.34% 2.78B -3.12% 2.27B +28.26% 1.77B +3.15% 1.49B +35.33% 1.62B
Automotive Accessories
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
KUMHO HT, INC. 
